{"id":1456,"date":"2026-02-26T14:33:13","date_gmt":"2026-02-26T14:33:13","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/26\/ocrevus-and-tysabri-appear-to-work-equally-well-to-control-relapsing-ms\/"},"modified":"2026-02-26T14:33:13","modified_gmt":"2026-02-26T14:33:13","slug":"ocrevus-and-tysabri-appear-to-work-equally-well-to-control-relapsing-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/26\/ocrevus-and-tysabri-appear-to-work-equally-well-to-control-relapsing-ms\/","title":{"rendered":"Ocrevus and Tysabri appear to work equally well to control relapsing MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/26\/tysabri-ocrevus-work-equally-well-relapsing-ms-new-study\/\" title=\"Ocrevus and Tysabri appear to work equally well to control relapsing MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/02\/iStock-1333253892-800x533.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"An image of a scale is superimposed over cupped hands of a person wearing a lab coat and stethoscope.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"159885\" \/><\/a><\/p>\n<p>Two of the most effective treatments for relapsing-remitting multiple sclerosis (MS) \u2014\u00a0Ocrevus (ocrelizumab) and Tysabri (natalizumab) \u2014 are essentially matched in their ability to control the disease, a new nationwide study from Denmark suggests. Researchers found no significant difference between the two therapies in preventing relapses, slowing disability progression, or reducing brain lesions. \u201cThere is [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/26\/tysabri-ocrevus-work-equally-well-relapsing-ms-new-study\/\">Ocrevus and Tysabri appear to work equally well to control relapsing MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/26\/tysabri-ocrevus-work-equally-well-relapsing-ms-new-study\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Two of the most effective treatments for relapsing-remitting multiple sclerosis (MS) \u2014\u00a0Ocrevus (ocrelizumab) and Tysabri (natalizumab) \u2014 are essentially matched in their ability to control the disease, a new nationwide study from Denmark suggests. Researchers found no significant difference between the two therapies in preventing relapses, slowing disability progression, or reducing brain lesions. \u201cThere is&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1457,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1456","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1456"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1456\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1457"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}